RxDoctor Payments Data

Aneesha Shetty

Nephrology · Tucson, AZNPI 1841505070

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 92.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $11,617 and has fallen 83.6% since, to $1,900 in 2025. Among nephrology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,486in general payments, 2019–2025

Across 43 payments — averaging $802.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Veloxis Pharmaceuticals, Inc.$32K
  • Calliditas Therapeutics US Inc.$2K
  • Sanofi-aventis U.S. LLC$256
  • GSK$118
  • Sanofi$24
  • Merck$22
$17,516in research payments, 2019–2025

Across 1 payment — averaging $17,516 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$18K

What the payments were for

  • Consulting fees$17,10050%
  • Speaking & faculty fees$6,62819%
  • Travel & lodging$8,35624%
  • Food & beverage$2,3857%
  • Education$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,486 in reported general payments places this provider in the 95th percentile of 259 nephrology providers in Arizona.

See all nephrology providers in Arizona

Medicare billing

Part B allowed, 2024
$22,073
Medicare patients
51
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OctagamImmun Globg(Igg)/Malt/Iga Ov5019$447,644
JardianceEmpagliflozin43$31,743
OzempicSemaglutide28$26,621
EliquisApixaban23$13,582
Humalog Kwikpen U-100Insulin Lispro25$5,376
Valganciclovir Hcl13$3,932
Fluconazole59$2,136
Cinacalcet Hcl34$1,435
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$1,368
Ultra-Fine Micro Pen NeedlePen Needle, Diabetic14$1,117
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic13$964
Prednisone98$518
Tamsulosin Hcl45$513
Nifedipine ErNifedipine41$424
Atorvastatin Calcium48$352

Paid to pharmacies, not to this prescriber.

Other nephrology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →